![PDF) Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial PDF) Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial](https://i1.rgstatic.net/publication/344198837_Short-Term_Changes_in_Albuminuria_and_Risk_of_Cardiovascular_and_Renal_Outcomes_in_Type_2_Diabetes_Mellitus_A_Post_Hoc_Analysis_of_the_EMPA-REG_OUTCOME_Trial/links/600e880f45851553a06b2547/largepreview.png)
PDF) Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
صور حزينه - هذا انا 🙋اعشق😍 الصمت😯 احيانآ اكون غامض😮 ابتسم😄 رغم همي 😭اضحك😁رغم حزني 😩لا احد يعلم مابدخلي💁 سوآ خالقي☝انا🙋ساظل كما انا 🙋خجول 😊غيور😡 كلي هدو😌 اظهر مشاعري😍 بكل صراحه😇 واخفي
![PDF) Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial PDF) Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial](https://i1.rgstatic.net/publication/362506726_Effect_of_Canagliflozin_on_Total_Cardiovascular_Burden_in_Patients_With_Diabetes_and_Chronic_Kidney_Disease_A_Post_Hoc_Analysis_From_the_CREDENCE_Trial/links/62f81b41c6f6732999cbca0f/largepreview.png)
PDF) Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial
![PDF) Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial PDF) Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial](https://i1.rgstatic.net/publication/350941425_Effects_of_dapagliflozin_on_mortality_in_patients_with_chronic_kidney_disease_a_pre-specified_analysis_from_the_DAPA-CKD_randomized_controlled_trial/links/607a8480907dcf667ba46201/largepreview.png)